Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Rang in aandelen #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Aandeelprijs
$88.89
Marktkapitalisatie
$114.13B
Verandering (1 dag)
-0.93%
Verandering (1 jaar)
-2.08%
Land
IE
Handel Medtronic plc (2M6)

Categorie

Winst voor Medtronic plc (2M6)
Winst in Jan 2026 TTM: $5.56B
Volgens de meest recente financiële verslagen van Medtronic plc bedraagt de huidige winst van het bedrijf $5.56B. In 2024 behaalde het bedrijf een winst van $4.84B, een daling ten opzichte van de winst van 2023, die $5.36B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Medtronic plc van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $5.56B -1.13%
2025 $5.63B 16.35%
2024 $4.84B -9.82%
2023 $5.36B -2.77%
2022 $5.52B 41.64%
2021 $3.90B -3.95%
2020 $4.06B -21.97%
2019 $5.20B -8.42%
2018 $5.68B 23.32%
2017 $4.60B 6.13%
2016 $4.34B 24.38%
2015 $3.49B -5.91%
2014 $3.71B -12.84%
2013 $4.25B 2.56%
2012 $4.15B 11.33%
2011 $3.72B -6.20%
2010 $3.97B 53.01%
2009 $2.59B -10.09%
2008 $2.89B -17.92%
2007 $3.52B 11.19%
2006 $3.16B 24.29%
2005 $2.54B -9.06%
2004 $2.80B 19.46%
2003 $2.34B 53.61%
2002 $1.52B -1.63%
2001 $1.55B -4.89%
2000 $1.63B 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$8.47B 52.15%
US
$4.51B -18.88%
US
$5.56B -0.02%
IE
$3.39B -39.17%
US
$3.13B -43.72%
DE